KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Capital Expenditures (2016 - 2025)

Cme (CME) has disclosed Capital Expenditures for 17 consecutive years, with $32.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 24.05% to $32.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $83.5 million, a 11.17% decrease, with the full-year FY2025 number at $83.5 million, down 11.17% from a year prior.
  • Capital Expenditures was $32.5 million for Q4 2025 at Cme, up from $18.4 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $39.7 million in Q2 2021 to a low of $14.2 million in Q1 2025.
  • A 5-year average of $23.5 million and a median of $22.1 million in 2022 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: tumbled 61.0% in 2021, then surged 49.75% in 2024.
  • Cme's Capital Expenditures stood at $27.3 million in 2021, then fell by 10.62% to $24.4 million in 2022, then fell by 14.75% to $20.8 million in 2023, then grew by 25.96% to $26.2 million in 2024, then increased by 24.05% to $32.5 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Capital Expenditures are $32.5 million (Q4 2025), $18.4 million (Q3 2025), and $18.4 million (Q2 2025).